Mitchell W. Kitayama - Nov 22, 2024 Form 4 Insider Report for Astrana Health, Inc. (ASTH)

Role
Director
Signature
/s/ Kathy Diep, as Attorney-in-Fact
Stock symbol
ASTH
Transactions as of
Nov 22, 2024
Transactions value $
$16
Form type
4
Date filed
11/26/2024, 04:15 PM
Previous filing
Sep 11, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ASTH Common Stock Options Exercise $62.8K +3.41K +19.16% $18.41 21.2K Nov 22, 2024 Direct
transaction ASTH Common Stock Tax liability -$62.7K -1.49K -7.03% $42.11 19.7K Nov 22, 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ASTH Stock Option (right to buy) Options Exercise $0 -3.41K -100% $0.00 0 Nov 22, 2024 Common Stock 3.41K $18.41 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These stock options were fully vested and exercisable.
F2 Includes 6,750 shares of restricted stock, which will vest on December 9, 2024, and 3,564 shares of restricted stock, which will vest on the earlier of August 13, 2025 or the date of the Issuer's 2025 annual meeting of stockholders.